PROTO SCRIPT PHARMACEUTICAL CORP: key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2015)
- $881.4K
- Net Income/Loss (FY2015)
- -$33.1K
- Total Assets (FY2015)
- $11.8K
- Total Equity (FY2015)
- -$77.1K
- Cash Flows from Operating Activities (FY2015)
- -$38.2K
Source: PROTO SCRIPT PHARMACEUTICAL CORP 10-K/A filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
